Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Catalio Capital

WebsiteLinkedInTwittercbCrunchbase
Status
Active
Global HQ
New York City, United States
Countries of investment
  • United States
  • United Kingdom
  • Germany
Investment stages
  • Seed
  • Series B
Industries
  • Bio / Life‑Science
About
Catalio Capital is a life sciences investor focused on breakthrough platforms. The firm partners with scientists to accelerate commercialization.
Min check size
$5K
Max check size
$40M
Fund size
NPS

Investment Thesis

Invests in platform biotech companies specializing in diagnostics, therapeutics, and pharmaceutical innovation.
Lead investor
Co Invest
Number of exits
Preferred contact method

Catalio Capital Contacts Information

Primary contact

Secondary contact

Portfolio

AdvanCell

Affini‑T

Alentis Therapeutics

Anagenex

ArriVent

Ashvattha Therapeutics

Atai Life Sciences

Audicus

Avalyn Pharma

AVAVA

Aviceda Therapeutics

Bayesian Health

Blackrock Neurotech

Boost Neuroscience

Cage Pharmaceuticals

Cambrian Biopharma

Carbon Health

Cartography

Celsius Therapeutics

Centenara Labs

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp